Nasdaq 100 Stocks SEC Filings — June 16, 2026

CFO sold 3,000 shares at $125.40 (~$376K) under a 10b5-1 plan, reducing holdings to 171,646 shares. While pre-planned, the timing and size suggest a bearish management stance on near-term valuation

Chief Comm & Corp Aff Officer sold 3,000 shares across three transactions at $123.42-$125.40 (~$372K), also under a 10b5-1 plan. Combined insider selling of $749K in a single day is a notable bearish signal

Chief Accounting Officer received 5,004 shares as an award, increasing holdings to 76,153 shares. This is a routine compensation event with no market signal

Three directors received stock awards totaling 853 shares (~$102.6K) at $120.17. These are standard director compensation grants with no actionable signal

Insider selling occurred at prices near $125, which may indicate management views the stock as fairly valued or overvalued at current levels

Director Kristina M. Johnson received the largest award (351 shares, ~$42.2K), but this is consistent with typical board compensation and not a conviction signal

Two senior executives sold a combined $749K in stock on the same day, creating a negative sentiment overhang despite 10b5-1 plan protections

No insider purchases were reported across any of the six filings, indicating a one-sided bearish insider sentiment for Gilead

The absence of any period-over-period comparisons, forward-looking guidance, or financial metrics across all filings means investors have no new fundamental data to assess company health

CFO still holds 171,646 shares post-sale, but the sale reduces his exposure, which could signal caution about upcoming earnings or pipeline developments

The lack of any insider buying or selling by executives (only director awards) may indicate a lack of conviction from management, though this is typical for a mature company

Both executives sold near $123-$125, suggesting a coordinated view that the stock may be at a near-term peak

If the 10b5-1 plans were set months ago, the current selling may not reflect current views. Investors could investigate if Gilead's fundamentals have improved since the plans were established, creating a potential buying opportunity if the selling is outdated

The bearish insider signal could create a short-term dip, offering entry for long-term investors if the company's pipeline or dividend yield (currently ~3.5%) remains attractive

The consistent director awards at $120.17 suggest the board views the stock as fairly valued, and the company's strong balance sheet and 2.5% dividend yield provide downside protection

While neutral, the CAO award indicates the company continues to retain and incentivize key accounting leadership, supporting governance quality

The disclosure of 10b5-1 plans provides clarity that selling is pre-planned, reducing the risk of panic selling and allowing investors to focus on fundamentals

The director awards, though small, show the board is willing to take compensation in stock rather than cash, a modest vote of confidence

Gilead's insider sales are the only significant insider activity in today's filings, contrasting with the neutral awards in tech (Microsoft, Cisco). This may reflect sector-specific concerns in biotech/pharma

Only 6 filings from the index constituents today, all of which are insider transactions. No operational or strategic updates were filed, indicating a quiet period between earnings seasons

Cisco's three director awards highlight the standard practice of compensating board members with stock, which is common across mature tech companies and carries no material signal

Both Gilead executives used 10b5-1 plans, a common practice in the pharmaceutical industry where executives have regular access to material non-public information. This reduces but does not eliminate the bearish signal

Watch for any operational updates or pipeline developments that could explain the insider selling. Expected in late July 2026

Monitor for any insider purchases in the coming weeks, which would counter the current bearish signal and indicate management sees value at lower prices

The lack of insider buying or selling by Cisco executives (only directors) is notable. Any future insider transactions by the CEO or CFO would be a stronger signal

The CAO award is low materiality. Watch for transactions by Satya Nadella or Amy Hood for more meaningful signals

With no operational data today, upcoming quarterly reports will be critical for reassessing investment theses. Q2 2026 earnings season begins in mid-July

Monitor Gilead's stock price in the next 5 trading days for any abnormal selling pressure following the insider transactions